Respiratory Inhaler Devices MarketThe global respiratory inhaler devices market, valued at USD 37,258.5 million in 2023, is projected to grow at a compound annual growth rate (CAGR) of 4.90%, reaching ...

Winter is prime time for COPD. You can’t get rid of the disease, but treatment can improve quality of life.Key takeaways:COPD ...

Therapies that target the prostacyclin pathway hold promise as chronic CTEPH treatment, a meta-analysis of controlled trials ...

Purpose. Special considerations in the selection of medication inhaler devices for elderly patients with chronic obstructive pulmonary disease (COPD) in the ambulatory care setting are reviewed.

Pulmonary aspiration occurs when stomach contents enter the lungs ... especially in patients undergoing surgeries where ...

Understand the role of palliative care and hospice for COPD patients. COPD Pharmacological Management Identify medications used in COPD management and differentiate between action pathways of common ...

Alexander Mathioudakis, MD, PhD, clinical lecturer in respiratory medicine at The University of Manchester, discusses insights from the FLAME trial analysis and the ICS-RECODE meta-analysis.

An estimated 30 million Americans are affected by chronic obstructive pulmonary disease (COPD), but surprisingly, only 17 million have received a diagnosis. Texas alone accounts for 1.2 million of ...

Background In asthma and COPD, inhalers are a significant contributor to treatment-related carbon footprint. Over the past decade, relative use of Dry Powder Inhalers (DPIs) has declined while the use ...

So, the new label now warns that rare cases of pulmonary aspiration have been reported in patients taking GLP-1 medications ...

and recent studies have shown they may favour inhalers with more environmentally-friendly credentials. We sought to measure how willing patients with asthma and chronic obstructive pulmonary disease ...